NEW YORK April 20 2017 PRNewswire Immune Pharmaceuticals Inc. NASDAQ IMNP "Immune" or "Immune Pharma" announced today that it has entered into a letter of intent with Pint Pharma GmnH a pharmaceutical company focused on Latin America a...
↧